Literature DB >> 24526194

Alport syndrome: a rare cause of uraemia.

Soumik Ghosh1, Manavdeep Singh, Ratnakar Sahoo, Sachin Rao.   

Abstract

Alport syndrome (AS) is a heterogeneous basement membrane disease characterised by haematuria with progressive hereditary nephritis, high-frequency sensorineural hearing loss (SNHL) and pathognomonic ocular lesions. It is one of the spectra of diseases representing hereditary nephritis, which inevitably leads to end-stage renal disease (ESRD). Microscopic or frank haematuria persistent from childhood constitutes the clinical clue for its early recognition. It occurs as a result of genetically inherited or de novo mutations in type IV collagen genes. The most common mode of inheritance is X-linked and men are more severely affected. We report a case of a young woman, in her fourth decade of life presenting with overt nephropathy, having persistent haematuria associated with SNHL and lenticonus with dot and fleck retinopathy on detailed clinical examination, diagnosed as a previously undetected case of Alport syndrome.

Entities:  

Mesh:

Year:  2014        PMID: 24526194      PMCID: PMC3926451          DOI: 10.1136/bcr-2013-201731

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  17 in total

Review 1.  Estimating prevalence in single-gene kidney diseases progressing to renal failure.

Authors:  M Levy; J Feingold
Journal:  Kidney Int       Date:  2000-09       Impact factor: 10.612

2.  Immunochemical studies of the Alport antigen.

Authors:  M M Kleppel; W W Fan; H I Cheong; C E Kashtan; A F Michael
Journal:  Kidney Int       Date:  1992-06       Impact factor: 10.612

3.  Diagnosing Alport syndrome using electron microscopy of the skin.

Authors:  A Kuroki; J Ito; A Yokochi; N Kato; T Sugisaki; H Sueki; T Akizawa
Journal:  Kidney Int       Date:  2008-02       Impact factor: 10.612

4.  Ocular abnormalities in patients with Alport's syndrome.

Authors:  A Vanderschueren; I Stalmans; R Lombaerts; A Leys
Journal:  Nephrol Dial Transplant       Date:  1996-11       Impact factor: 5.992

5.  COL4A4 mutation in thin basement membrane disease previously described in Alport syndrome.

Authors:  M Buzza; Y Y Wang; H Dagher; J J Babon; R G Cotton; H Powell; J Dowling; J Savige
Journal:  Kidney Int       Date:  2001-08       Impact factor: 10.612

Review 6.  Genetics of classic Alport's syndrome.

Authors:  F A Flinter; J S Cameron; C Chantler; I Houston; M Bobrow
Journal:  Lancet       Date:  1988-10-29       Impact factor: 79.321

7.  Identification of post-transplant anti-alpha 5 (IV) collagen alloantibodies in X-linked Alport syndrome.

Authors:  P Dehan; L P Van den Heuvel; H J Smeets; K Tryggvason; J M Foidart
Journal:  Nephrol Dial Transplant       Date:  1996-10       Impact factor: 5.992

Review 8.  Familial hematuria.

Authors:  Clifford E Kashtan
Journal:  Pediatr Nephrol       Date:  2007-10-02       Impact factor: 3.714

9.  Alport's syndrome of hereditary nephritis with deafness.

Authors:  D A WILLIAMSON
Journal:  Lancet       Date:  1961-12-16       Impact factor: 79.321

10.  Skin biopsy for the diagnosis of Alport syndrome.

Authors:  E Lagona; L Tsartsali; S Kostaridou; A Skiathitou; E Georgaki; F Sotsiou
Journal:  Hippokratia       Date:  2008-04       Impact factor: 0.471

View more
  2 in total

1.  Genetic background influences cardiac phenotype in murine chronic kidney disease.

Authors:  Samantha Neuburg; Corey Dussold; Claire Gerber; Xueyan Wang; Connor Francis; Lixin Qi; Valentin David; Myles Wolf; Aline Martin
Journal:  Nephrol Dial Transplant       Date:  2018-07-01       Impact factor: 5.992

2.  Podocytes regulate the glomerular basement membrane protein nephronectin by means of miR-378a-3p in glomerular diseases.

Authors:  Janina Müller-Deile; Jan Dannenberg; Patricia Schroder; Meei-Hua Lin; Jeffrey H Miner; Rongjun Chen; Jan-Hinrich Bräsen; Thomas Thum; Jenny Nyström; Lynne Beverly Staggs; Hermann Haller; Jan Fiedler; Johan M Lorenzen; Mario Schiffer
Journal:  Kidney Int       Date:  2017-05-03       Impact factor: 10.612

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.